In the dominant model, NR5A2 rs3790844 polymorphism was associated with significantly lower risk of death in the groups of patients with lymph node metastasis, no distant metastasis, diffuse type and no chemotherapy history (log-rank p < 0.05). This evidence concerns the gene NR5A2 and metastatic malignant neoplasm in the lymph nodes.